Literature DB >> 372236

Adenosine deaminase deficiency: disappearance of adenine deoxynucleotides from a patient's erythrocytes after successful marrow transplantation.

S H Chen, H D Ochs, C R Scott, E R Giblett, A J Tingle.   

Abstract

Accumulation of adenine deoxynucleotides (dATP and dADP) in the erythrocytes of a patient with adenosine deaminase (ADA) deficiency was confirmed. The patient, now 18 mo old, was treated with a bone marrow transplantation from his HLA identical sister at 7 mo of age. Before and after the transplant, his erythrocyte and lymphocyte ADA activities, as well as his erythrocyte nucleotide profiles, were measured. 10 wk after the marrow transplant, no ADA activity could be detected in his erythrocytes, whereas there was a mixture of donor and patient lymphocytes as measured by ADA assays and karyotyping. At the same time, both dATP and dADP had disappeared from his erythrocytes, which were entirely of patient origin. These findings indicate that partial engraftment of donor lymphocytes into an ADA-deficient patient is capable of "correcting" alterations of deoxynucleotide concentrations in the patient's ADA-deficient erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 372236      PMCID: PMC371904          DOI: 10.1172/JCI109259

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  13 in total

1.  SEPARATION OF DEOXYRIBONUCLEOTIDES FROM RIBONUCLEOTIDES BY ANION-EXCHANGE THIN-LAYER CHROMATOGRAPHY.

Authors:  K RANDERATH
Journal:  Biochim Biophys Acta       Date:  1963-12-20

2.  Alternative pathways of deoxyadenosine and adenosine metabolism.

Authors:  F F Snyder; J F Henderson
Journal:  J Biol Chem       Date:  1973-08-25       Impact factor: 5.157

3.  Separation of blood leucocytes, granulocytes and lymphocytes.

Authors:  A Boyum
Journal:  Tissue Antigens       Date:  1974

4.  Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity.

Authors:  E R Giblett; J E Anderson; F Cohen; B Pollara; H J Meuwissen
Journal:  Lancet       Date:  1972-11-18       Impact factor: 79.321

5.  Overproduction of adenine deoxynucleosides and deoxynucletides in adenosine deaminase deficiency with severe combined immunodeficiency disease.

Authors:  J Donofrio; M S Coleman; J J Hutton; A Daoud; B Lampkin; J Dyminski
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

6.  Identification and quantitation of adenine deoxynucleotides in erythrocytes of a patient with adenosine deaminase deficiency and severe combined immunodeficiency.

Authors:  M S Coleman; J Donofrio; J J Hutton; L Hahn; A Daoud; B Lampkin; J Dyminski
Journal:  J Biol Chem       Date:  1978-03-10       Impact factor: 5.157

7.  Increased purine nucleotides in adenosine deaminase-deficient lymphocytes.

Authors:  F C Schmalstieg; J A Nelson; G C Mills; T M Monahan; A S Goldman; R M Goldblum
Journal:  J Pediatr       Date:  1977-07       Impact factor: 4.406

8.  Detection of the carrier state in combined immunodeficiency disease associated with adenosine deaminase deficiency.

Authors:  C R Scott; S H Chen; E R Giblett
Journal:  J Clin Invest       Date:  1974-04       Impact factor: 14.808

9.  Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.

Authors:  A Cohen; R Hirschhorn; S D Horowitz; A Rubinstein; S H Polmar; R Hong; D W Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

10.  Purine metabolism in adenosine deaminase deficiency.

Authors:  G C Mills; F C Schmalstieg; K B Trimmer; A S Goldman; R M Goldblum
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

View more
  10 in total

1.  Varicella pneumonia in a bone marrow-transplanted, immune-reconstituted adenosine deaminase-deficient patient with severe combined immunodeficiency disease.

Authors:  M Ballow; R Hirschhorn
Journal:  J Clin Immunol       Date:  1985-05       Impact factor: 8.317

2.  HLA-haploidentical bone marrow transplantation in three infants with adenosine deaminase deficiency: stable immunological reconstitution and reversal of skeletal abnormalities.

Authors:  R Bluetters-Sawatzki; W Friedrich; W Ebell; U Vetter; H Stoess; S F Goldmann; E Kleihauer
Journal:  Eur J Pediatr       Date:  1989-11       Impact factor: 3.183

3.  Pathologic findings in adenosine deaminase-deficient severe combined immunodeficiency. I. Kidney, adrenal, and chondro-osseous tissue alterations.

Authors:  H Ratech; M A Greco; G Gallo; D L Rimoin; H Kamino; R Hirschhorn
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

4.  Immunoreconstitution by peripheral blood leukocytes in adenosine deaminase-deficient severe combined immunodeficiency.

Authors:  K C Rich; C M Richman; E Mejias; P Daddona
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

5.  Transient expression of human adenosine deaminase cDNAs: identification of a nonfunctional clone resulting from a single amino acid substitution.

Authors:  S H Orkin; S C Goff; W N Kelley; P E Daddona
Journal:  Mol Cell Biol       Date:  1985-04       Impact factor: 4.272

6.  ATP depletion as a consequence of adenosine deaminase inhibition in man.

Authors:  M F Siaw; B S Mitchell; C A Koller; M S Coleman; J J Hutton
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

7.  Plasma deoxyadenosine, adenosine, and erythrocyte deoxyATP are elevated at birth in an adenosine deaminase-deficient child.

Authors:  R Hirschhorn; V Roegner; A Rubinstein; P Papageorgiou
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

Review 8.  Enzymatic Transition States and Drug Design.

Authors:  Vern L Schramm
Journal:  Chem Rev       Date:  2018-10-18       Impact factor: 60.622

9.  Bone marrow transplantation only partially restores purine metabolites to normal in adenosine deaminase-deficient patients.

Authors:  R Hirschhorn; V Roegner-Maniscalco; L Kuritsky; F S Rosen
Journal:  J Clin Invest       Date:  1981-12       Impact factor: 14.808

10.  Genetic markers in human bone marrow transplantation.

Authors:  K G Blume; E Beutler; K J Bross; G M Schmidt; W E Spruce; R L Teplitz
Journal:  Am J Hum Genet       Date:  1980-05       Impact factor: 11.025

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.